Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Immunoproliferative Disorders
>>
Roche
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Valcyte
(valganciclovir) / Roche, Mitsubishi Tanabe
RG4733
/ Roche
Zelboraf
(vemurafenib) / Roche
Actemra IV
(tocilizumab) / Roche, JW Pharma
Erivedge
(vismodegib) / Roche
Herceptin
(trastuzumab) / Roche
PRO131921
/ Roche
Vesanoid
(tretinoin) / Roche
SPC2996
/ Roche
Viracept
(nelfinavir) / ViiV Healthcare, Roche
drozitumab
(RG7425) / Roche
dulanermin
(AMG 951) / Amgen, Roche
pinatuzumab vedotin
(RG7593) / Roche
